TP53 and cancer: In view of the fact that homozygous p53 mutants die at an early age from cancer (Donehower et al., 1992), we generated compound mutant mice that were homozygous for 1α(OH)ase deletion and heterozygous for p53 mutation and compared their phenotypes with 1,25(OH)2D3‐deficient mice.